Leman Biotech's New Metabolically Enhanced Immunotherapy Reported by SWI Swissinfo.ch
SWI swissinfo.ch recently highlighted Leman Biotech in research development of cancer immunotherapy in Switzerland. The article focuses on the innovative research conducted by Professor Li Tang, co-founder of Leman Biotech, and his research team, Laboratory of Biomaterials for Immunoengineering. The research aims at overcoming T-cell exhaustion and improving the efficacy of current immunotherapies. The article sheds light on Leman Biotech's cutting-edge approach and its potential to revolutionize cancer treatment.